Executive Summary: The global Randomization and Trial Supply Management market was valued at  USD 258.54 million in 2024  and is expected to reach  USD 790.90 million by 2032.  During the forecast period of 2025 to 2032 the market is likely to grow at a  CAGR of 15.00%,  primarily driven by the increasing number of clinical trials and rising demand for efficient...